The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Trends in AMR-related hospitalizations over the past decade were inconsistent and varied by causative pathogen, indicating the overall burden of AMR remains substantial.

A substantial burden of hospitalizations for PIV-associated ARI was observed among pediatric patients in the United States.

Early prediction of in-hospital pneumonia mortality can effectively be done using a machine learning (ML) model based on clinical data.

Clinicians consider administration of human papillomavirus vaccine as feasible at age 9 to 10 years, and parents appear to be receptive.

Salmonella-tainted tomatoes in 3 southern states could cause severe illness or even death, the US Food and Drug Administration warns.

In a new clinical practice guideline, recommendations are presented for the surgical management of chronic rhinosinusitis in adults.

There was a decline in hospitalizations and in-hospital mortality due to COVID-19 between 2023 and 2024, a period spanning the XBB, JN.1, and KP eras.

Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.

Remdesivir was associated with a significant survival benefit and reduced risk for rehospitalization among inpatients with COVID-19 infection.

Procalcitonin levels greater than 0.9 ng/mL may be a useful biomarker for identifying bacterial infections among febrile patients with JSLE.

Between 1999 and 2019 in the US, deaths related to hypertrophic cardiomyopathy decreased, but then significantly increased during the COVID-19 pandemic.